secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2025-06-30T23:59:59+00:00
Accession:  0000950170-25-091581
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo raises $15.9M in Q2 equity offerings, believes it regains Nasdaq compliance on stockholders' equity
--------------------------------------------------------------------------------

- Raised approx. $15.9M via four equity transactions: April 4 ($2.1M), April 22 ($2.0M), June 20 ($8.0M), and ATM facility ($3.8M).
- Company believes stockholders' equity now exceeds the $2.5M minimum required by Nasdaq Listing Rule 5550(b)(1).
- Awaiting formal confirmation from Nasdaq of compliance; previously disclosed deficiency for quarter ended March 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025091581/0000950170-25-091581-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025091581/apvo-20250630.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-091581

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer